Limited (“ HUTCHMED ”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that it has initiated the Phase III part of the Phase II/III trial to evaluate the efficacy of the combination of surufatinib, ...

CystoSmart™, an AI software tool for bladder tumor detection in patients undergoing screening and surveillance endoscopic examination of the bladder is brand agnostic and compatible with flexible and ...

Melatonin supplements are popular sleeping aid in 2026 and are mainly used by individuals having an impaired melatonin cycle. In many studies, a connection was established between melatonin production ...

Performer 8 is our top choice for the best male enhancement pill of 2026. While women receive a "second peak" of sexual boost in their 40s, men tend to see their libidos decline. Some of Europe's most ...

Discover how CJC-1295 peptide stack research has influenced CrazyBulk’s Growth Hormone Stack, designed to support recovery speed, lean muscle, and training output. Intro. New Yo ...

Winnipeg, MB - January 2nd, 2026 - Mint Ops, a national ecosystem of services supporting dental clinics across Canada, today announced the official launch of its fifth Division: Transition Consulting, ...

CINCINNATI, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2025, on Wednesday, ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its fourth quarter and full year 2025 financial and operating results on Friday, January 30, 2026, before the U.S.

With this 500-review milestone, Clínica García-Dihinx reaffirms its ongoing mission to provide a safe, ethical, and results-driven approach to plastic surgery, while remaining accessible and ...

Genelux Corporation ( NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced the appointment of Jason Litten, M.D., as Chief Medical Officer, effective January 2, 2026. Dr.

Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the closing of its ...

RxSight’s management is scheduled to present on Tuesday, January 13, 2026, at 3:45 p.m. Pacific Time / 6:45 p.m. Eastern Time. Interested parties may access a live and archived webcast of the ...